PHS HAS DEVELOPED, PURSUANT TO SECTION
340B OF THE PHS ACT, AUDIT GUIDELINES AND A DISPUTE RESOLUTION
PROCESS FOR THE DRUG PRICING PROGRAM. THE ASSOCIATED REPORTING
REQUIREMENTS ARE NECESSARY TO PROVI PARTICIPATING ENTITIES WITH
PROTECTION FROM ABUSE AUDITS AND TO PROVID THE INFORMATION
NECESSARY TO GIVE ENTITIES AND MANUFACTURERS FAIR "NOTICE AND
HEARING" OPPORTUNITIES.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.